Apple Unveils New Chips For Mobile
A9, A9X promise large performance improvements
Jessica Lipsky, EETimes
9/9/2015 08:10 PM EDT
SAN FRANCISCO — Apple rented out a much larger venue — the 7,000-person capacity Bill Graham Civic Auditorium in downtown San Francisco — to unveil today (Sept 9) a handful of devices that are much, much smaller. The company’s new iPad and iPhone will run new processors with an updated architecture.
The iPad Pro runs on a 64-bit A9X, Apple’s third generation of custom designed processors. While Apple was expectedly short on details, officials announced that A9X has twice the memory bandwidth of last year’s A8X and is 1.8 times faster than the 8X processor inside the Macbook Air 2 for “desktop-class performance.” The tablet supports 802.11ac MIMO and up to 150 Mbits/second LTE.
|
|
E-mail This Article |
|
Printer-Friendly Page |
Related News
- Silicon IP Provider, Chips&Media Unveils New Multi Video Codec IP, WAVE6 Gen2+
- intoPIX unveils new FastTicoRAW & FastTicoXS codecs for Apple silicon and makes the switch to ARM-based technology simple
- Alibaba Cloud Unveils New Server Chips to Optimize Cloud Computing Services
- Is Apple planning to acquire Intel's mobile business?
- GLOBALFOUNDRIES Delivering 8SW RF SOI Client Chips on 300mm Platform for Next-Generation Mobile Applications
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design






